Evidence map›Paper›PMID 37397178›Full record

Observational studyBulletin of the World Health Organization2023

Implementation research: including breast examinations in a cervical cancer screening programme, Rwanda.

Lydia E Pace, Marc Hagenimana, Jean-Marie Vianney Dusengimana, Jean Paul Balinda, Origene Benewe, Vestine Rugema, Jean de Dieu Uwihaye, Amanda Fata, Cyprien Shyirambere, Lawrence N Shulman and 2 more

Open access · diamondAbstract readObservational Study
In one paragraph

Observational study in Bulletin of the World Health Organization, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Lydia E PaceDivision of Women's Health, Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA02115, United States of America (USA).
Marc HagenimanaRwanda Biomedical Centre, Kigali, Rwanda.
Jean-Marie Vianney DusengimanaPartners In Health, Kigali, Rwanda.
Jean Paul BalindaRwanda Biomedical Centre, Kigali, Rwanda.
Origene BenewePartners In Health, Kigali, Rwanda.
Vestine RugemaRwanda Ministry of Health, Burera District, Rwanda.
Jean de Dieu UwihayePartners In Health, Kigali, Rwanda.
Amanda FataDivision of Women's Health, Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA02115, United States of America (USA).
Cyprien ShyiramberePartners In Health, Kigali, Rwanda.
Lawrence N ShulmanAbramson Cancer Center, University of Pennsylvania, Philadelphia, USA.
Nancy L KeatingDepartment of Health Care Policy, Harvard Medical School, Boston, USA.
Francois UwinkindiRwanda Biomedical Centre, Kigali, Rwanda.
Rwanda Biomedical Center · RWHarvard University · USUniversity of Pennsylvania · US

Funding

Evaluating breast cancer care in rural RwandaK07CA215819 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI PACE, LYDIA · 2018 to 2023
$1.0M
NCI NIH HHS K07 CA215819
6 · The paper itself

Abstract

Objective: To evaluate whether integrating breast and cervical cancer screening in Rwanda's Women's Cancer Early Detection Program led to early breast cancer diagnoses in asymptomatic women. Methods: Launched in three districts in 2018-2019, the early detection programme offered clinical breast examination screening for all women receiving cervical cancer screening, and diagnostic breast examination for women with breast cancer symptoms. Women with abnormal breast examinations were referred to district hospitals and then to referral hospitals if needed. We examined how often clinics were held, patient volumes and number of referrals. We also examined intervals between referrals and visits to the next care level and, among women diagnosed with cancer, their initial reasons for seeking care. Findings: Health centres held clinics > 68% of the weeks. Overall, 9763 women received cervical cancer screening and clinical breast examination and 7616 received breast examination alone. Of 585 women referred from health centres, 436 (74.5%) visited the district hospital after a median of 9 days (interquartile range, IQR: 3-19). Of 200 women referred to referral hospitals, 179 (89.5%) attended after a median of 11 days (IQR: 4-18). Of 29 women diagnosed with breast cancer, 19 were ≥ 50 years and 23 had stage III or stage IV disease. All women with breast cancer whose reasons for seeking care were known (23 women) had experienced breast cancer symptoms. Conclusion: In the short-term, integrating clinical breast examination with cervical cancer screening was not associated with detection of early-stage breast cancer among asymptomatic women. Priority should be given to encouraging women to seek timely care for symptoms.

Indexed as

Breast NeoplasmsEarly Detection of CancerMass ScreeningUterine Cervical NeoplasmsAdultDelivery of Health Care, IntegratedFemaleHumansImplementation ScienceMiddle AgedProgram EvaluationRetrospective StudiesRwanda

Identifiers

PMID37397178
PMCPMC10300777
OpenAlexW4382919477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.